0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI for Pharma and Biotech Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-9R10644
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and United States AI for Pharma and Biotech Market Report Forecast 2022 2028
BUY CHAPTERS

Global AI for Pharma and Biotech Market Research Report 2025

Code: QYRE-Auto-9R10644
Report
July 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI for Pharma and Biotech Market Size

The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years.

AI for Pharma and Biotech Market

AI for Pharma and Biotech Market

The global market for AI for Pharma and Biotech was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Artificial intelligence used in Pharma and Biotech.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI for Pharma and Biotech, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI for Pharma and Biotech.
The AI for Pharma and Biotech market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI for Pharma and Biotech market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI for Pharma and Biotech companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of AI for Pharma and Biotech Market Report

Report Metric Details
Report Name AI for Pharma and Biotech Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Research Center
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CureMetrix, Enlitic, VoxelCloud, Insilico Medicine, Oncora Medical, Atomwise, TwoXAR, Berg Health, CloudMedX, Deep Genomics, Johnson & Johnson, Roche, Pfizer, Novartis, Bayer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of AI for Pharma and Biotech company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the AI for Pharma and Biotech Market report?

Ans: The main players in the AI for Pharma and Biotech Market are CureMetrix, Enlitic, VoxelCloud, Insilico Medicine, Oncora Medical, Atomwise, TwoXAR, Berg Health, CloudMedX, Deep Genomics, Johnson & Johnson, Roche, Pfizer, Novartis, Bayer

What are the Application segmentation covered in the AI for Pharma and Biotech Market report?

Ans: The Applications covered in the AI for Pharma and Biotech Market report are Hospital, Clinic, Research Center, Others

What are the Type segmentation covered in the AI for Pharma and Biotech Market report?

Ans: The Types covered in the AI for Pharma and Biotech Market report are Deep Learning, Big Data, Image Detection, Others

Recommended Reports

AI in Healthcare

Pharmaceutical Automation

Pharma R&D & Biotech

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI for Pharma and Biotech Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Deep Learning
1.2.3 Big Data
1.2.4 Image Detection
1.2.5 Others
1.3 Market by Application
1.3.1 Global AI for Pharma and Biotech Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI for Pharma and Biotech Market Perspective (2020-2031)
2.2 Global AI for Pharma and Biotech Growth Trends by Region
2.2.1 Global AI for Pharma and Biotech Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI for Pharma and Biotech Historic Market Size by Region (2020-2025)
2.2.3 AI for Pharma and Biotech Forecasted Market Size by Region (2026-2031)
2.3 AI for Pharma and Biotech Market Dynamics
2.3.1 AI for Pharma and Biotech Industry Trends
2.3.2 AI for Pharma and Biotech Market Drivers
2.3.3 AI for Pharma and Biotech Market Challenges
2.3.4 AI for Pharma and Biotech Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI for Pharma and Biotech Players by Revenue
3.1.1 Global Top AI for Pharma and Biotech Players by Revenue (2020-2025)
3.1.2 Global AI for Pharma and Biotech Revenue Market Share by Players (2020-2025)
3.2 Global AI for Pharma and Biotech Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI for Pharma and Biotech Revenue
3.4 Global AI for Pharma and Biotech Market Concentration Ratio
3.4.1 Global AI for Pharma and Biotech Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI for Pharma and Biotech Revenue in 2024
3.5 Global Key Players of AI for Pharma and Biotech Head office and Area Served
3.6 Global Key Players of AI for Pharma and Biotech, Product and Application
3.7 Global Key Players of AI for Pharma and Biotech, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI for Pharma and Biotech Breakdown Data by Type
4.1 Global AI for Pharma and Biotech Historic Market Size by Type (2020-2025)
4.2 Global AI for Pharma and Biotech Forecasted Market Size by Type (2026-2031)
5 AI for Pharma and Biotech Breakdown Data by Application
5.1 Global AI for Pharma and Biotech Historic Market Size by Application (2020-2025)
5.2 Global AI for Pharma and Biotech Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI for Pharma and Biotech Market Size (2020-2031)
6.2 North America AI for Pharma and Biotech Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI for Pharma and Biotech Market Size by Country (2020-2025)
6.4 North America AI for Pharma and Biotech Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI for Pharma and Biotech Market Size (2020-2031)
7.2 Europe AI for Pharma and Biotech Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI for Pharma and Biotech Market Size by Country (2020-2025)
7.4 Europe AI for Pharma and Biotech Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI for Pharma and Biotech Market Size (2020-2031)
8.2 Asia-Pacific AI for Pharma and Biotech Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI for Pharma and Biotech Market Size by Region (2020-2025)
8.4 Asia-Pacific AI for Pharma and Biotech Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI for Pharma and Biotech Market Size (2020-2031)
9.2 Latin America AI for Pharma and Biotech Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI for Pharma and Biotech Market Size by Country (2020-2025)
9.4 Latin America AI for Pharma and Biotech Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI for Pharma and Biotech Market Size (2020-2031)
10.2 Middle East & Africa AI for Pharma and Biotech Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI for Pharma and Biotech Market Size by Country (2020-2025)
10.4 Middle East & Africa AI for Pharma and Biotech Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CureMetrix
11.1.1 CureMetrix Company Details
11.1.2 CureMetrix Business Overview
11.1.3 CureMetrix AI for Pharma and Biotech Introduction
11.1.4 CureMetrix Revenue in AI for Pharma and Biotech Business (2020-2025)
11.1.5 CureMetrix Recent Development
11.2 Enlitic
11.2.1 Enlitic Company Details
11.2.2 Enlitic Business Overview
11.2.3 Enlitic AI for Pharma and Biotech Introduction
11.2.4 Enlitic Revenue in AI for Pharma and Biotech Business (2020-2025)
11.2.5 Enlitic Recent Development
11.3 VoxelCloud
11.3.1 VoxelCloud Company Details
11.3.2 VoxelCloud Business Overview
11.3.3 VoxelCloud AI for Pharma and Biotech Introduction
11.3.4 VoxelCloud Revenue in AI for Pharma and Biotech Business (2020-2025)
11.3.5 VoxelCloud Recent Development
11.4 Insilico Medicine
11.4.1 Insilico Medicine Company Details
11.4.2 Insilico Medicine Business Overview
11.4.3 Insilico Medicine AI for Pharma and Biotech Introduction
11.4.4 Insilico Medicine Revenue in AI for Pharma and Biotech Business (2020-2025)
11.4.5 Insilico Medicine Recent Development
11.5 Oncora Medical
11.5.1 Oncora Medical Company Details
11.5.2 Oncora Medical Business Overview
11.5.3 Oncora Medical AI for Pharma and Biotech Introduction
11.5.4 Oncora Medical Revenue in AI for Pharma and Biotech Business (2020-2025)
11.5.5 Oncora Medical Recent Development
11.6 Atomwise
11.6.1 Atomwise Company Details
11.6.2 Atomwise Business Overview
11.6.3 Atomwise AI for Pharma and Biotech Introduction
11.6.4 Atomwise Revenue in AI for Pharma and Biotech Business (2020-2025)
11.6.5 Atomwise Recent Development
11.7 TwoXAR
11.7.1 TwoXAR Company Details
11.7.2 TwoXAR Business Overview
11.7.3 TwoXAR AI for Pharma and Biotech Introduction
11.7.4 TwoXAR Revenue in AI for Pharma and Biotech Business (2020-2025)
11.7.5 TwoXAR Recent Development
11.8 Berg Health
11.8.1 Berg Health Company Details
11.8.2 Berg Health Business Overview
11.8.3 Berg Health AI for Pharma and Biotech Introduction
11.8.4 Berg Health Revenue in AI for Pharma and Biotech Business (2020-2025)
11.8.5 Berg Health Recent Development
11.9 CloudMedX
11.9.1 CloudMedX Company Details
11.9.2 CloudMedX Business Overview
11.9.3 CloudMedX AI for Pharma and Biotech Introduction
11.9.4 CloudMedX Revenue in AI for Pharma and Biotech Business (2020-2025)
11.9.5 CloudMedX Recent Development
11.10 Deep Genomics
11.10.1 Deep Genomics Company Details
11.10.2 Deep Genomics Business Overview
11.10.3 Deep Genomics AI for Pharma and Biotech Introduction
11.10.4 Deep Genomics Revenue in AI for Pharma and Biotech Business (2020-2025)
11.10.5 Deep Genomics Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Details
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson AI for Pharma and Biotech Introduction
11.11.4 Johnson & Johnson Revenue in AI for Pharma and Biotech Business (2020-2025)
11.11.5 Johnson & Johnson Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche AI for Pharma and Biotech Introduction
11.12.4 Roche Revenue in AI for Pharma and Biotech Business (2020-2025)
11.12.5 Roche Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Details
11.13.2 Pfizer Business Overview
11.13.3 Pfizer AI for Pharma and Biotech Introduction
11.13.4 Pfizer Revenue in AI for Pharma and Biotech Business (2020-2025)
11.13.5 Pfizer Recent Development
11.14 Novartis
11.14.1 Novartis Company Details
11.14.2 Novartis Business Overview
11.14.3 Novartis AI for Pharma and Biotech Introduction
11.14.4 Novartis Revenue in AI for Pharma and Biotech Business (2020-2025)
11.14.5 Novartis Recent Development
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer AI for Pharma and Biotech Introduction
11.15.4 Bayer Revenue in AI for Pharma and Biotech Business (2020-2025)
11.15.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global AI for Pharma and Biotech Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Deep Learning
 Table 3. Key Players of Big Data
 Table 4. Key Players of Image Detection
 Table 5. Key Players of Others
 Table 6. Global AI for Pharma and Biotech Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global AI for Pharma and Biotech Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global AI for Pharma and Biotech Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global AI for Pharma and Biotech Market Share by Region (2020-2025)
 Table 10. Global AI for Pharma and Biotech Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global AI for Pharma and Biotech Market Share by Region (2026-2031)
 Table 12. AI for Pharma and Biotech Market Trends
 Table 13. AI for Pharma and Biotech Market Drivers
 Table 14. AI for Pharma and Biotech Market Challenges
 Table 15. AI for Pharma and Biotech Market Restraints
 Table 16. Global AI for Pharma and Biotech Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global AI for Pharma and Biotech Market Share by Players (2020-2025)
 Table 18. Global Top AI for Pharma and Biotech Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI for Pharma and Biotech as of 2024)
 Table 19. Ranking of Global Top AI for Pharma and Biotech Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by AI for Pharma and Biotech Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of AI for Pharma and Biotech, Headquarters and Area Served
 Table 22. Global Key Players of AI for Pharma and Biotech, Product and Application
 Table 23. Global Key Players of AI for Pharma and Biotech, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global AI for Pharma and Biotech Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global AI for Pharma and Biotech Revenue Market Share by Type (2020-2025)
 Table 27. Global AI for Pharma and Biotech Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global AI for Pharma and Biotech Revenue Market Share by Type (2026-2031)
 Table 29. Global AI for Pharma and Biotech Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global AI for Pharma and Biotech Revenue Market Share by Application (2020-2025)
 Table 31. Global AI for Pharma and Biotech Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global AI for Pharma and Biotech Revenue Market Share by Application (2026-2031)
 Table 33. North America AI for Pharma and Biotech Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America AI for Pharma and Biotech Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America AI for Pharma and Biotech Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe AI for Pharma and Biotech Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe AI for Pharma and Biotech Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe AI for Pharma and Biotech Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific AI for Pharma and Biotech Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific AI for Pharma and Biotech Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific AI for Pharma and Biotech Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America AI for Pharma and Biotech Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America AI for Pharma and Biotech Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America AI for Pharma and Biotech Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa AI for Pharma and Biotech Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa AI for Pharma and Biotech Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa AI for Pharma and Biotech Market Size by Country (2026-2031) & (US$ Million)
 Table 48. CureMetrix Company Details
 Table 49. CureMetrix Business Overview
 Table 50. CureMetrix AI for Pharma and Biotech Product
 Table 51. CureMetrix Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 52. CureMetrix Recent Development
 Table 53. Enlitic Company Details
 Table 54. Enlitic Business Overview
 Table 55. Enlitic AI for Pharma and Biotech Product
 Table 56. Enlitic Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 57. Enlitic Recent Development
 Table 58. VoxelCloud Company Details
 Table 59. VoxelCloud Business Overview
 Table 60. VoxelCloud AI for Pharma and Biotech Product
 Table 61. VoxelCloud Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 62. VoxelCloud Recent Development
 Table 63. Insilico Medicine Company Details
 Table 64. Insilico Medicine Business Overview
 Table 65. Insilico Medicine AI for Pharma and Biotech Product
 Table 66. Insilico Medicine Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 67. Insilico Medicine Recent Development
 Table 68. Oncora Medical Company Details
 Table 69. Oncora Medical Business Overview
 Table 70. Oncora Medical AI for Pharma and Biotech Product
 Table 71. Oncora Medical Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 72. Oncora Medical Recent Development
 Table 73. Atomwise Company Details
 Table 74. Atomwise Business Overview
 Table 75. Atomwise AI for Pharma and Biotech Product
 Table 76. Atomwise Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 77. Atomwise Recent Development
 Table 78. TwoXAR Company Details
 Table 79. TwoXAR Business Overview
 Table 80. TwoXAR AI for Pharma and Biotech Product
 Table 81. TwoXAR Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 82. TwoXAR Recent Development
 Table 83. Berg Health Company Details
 Table 84. Berg Health Business Overview
 Table 85. Berg Health AI for Pharma and Biotech Product
 Table 86. Berg Health Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 87. Berg Health Recent Development
 Table 88. CloudMedX Company Details
 Table 89. CloudMedX Business Overview
 Table 90. CloudMedX AI for Pharma and Biotech Product
 Table 91. CloudMedX Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 92. CloudMedX Recent Development
 Table 93. Deep Genomics Company Details
 Table 94. Deep Genomics Business Overview
 Table 95. Deep Genomics AI for Pharma and Biotech Product
 Table 96. Deep Genomics Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 97. Deep Genomics Recent Development
 Table 98. Johnson & Johnson Company Details
 Table 99. Johnson & Johnson Business Overview
 Table 100. Johnson & Johnson AI for Pharma and Biotech Product
 Table 101. Johnson & Johnson Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 102. Johnson & Johnson Recent Development
 Table 103. Roche Company Details
 Table 104. Roche Business Overview
 Table 105. Roche AI for Pharma and Biotech Product
 Table 106. Roche Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 107. Roche Recent Development
 Table 108. Pfizer Company Details
 Table 109. Pfizer Business Overview
 Table 110. Pfizer AI for Pharma and Biotech Product
 Table 111. Pfizer Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 112. Pfizer Recent Development
 Table 113. Novartis Company Details
 Table 114. Novartis Business Overview
 Table 115. Novartis AI for Pharma and Biotech Product
 Table 116. Novartis Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 117. Novartis Recent Development
 Table 118. Bayer Company Details
 Table 119. Bayer Business Overview
 Table 120. Bayer AI for Pharma and Biotech Product
 Table 121. Bayer Revenue in AI for Pharma and Biotech Business (2020-2025) & (US$ Million)
 Table 122. Bayer Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. AI for Pharma and Biotech Picture
 Figure 2. Global AI for Pharma and Biotech Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global AI for Pharma and Biotech Market Share by Type: 2024 VS 2031
 Figure 4. Deep Learning Features
 Figure 5. Big Data Features
 Figure 6. Image Detection Features
 Figure 7. Others Features
 Figure 8. Global AI for Pharma and Biotech Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global AI for Pharma and Biotech Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Research Center Case Studies
 Figure 13. Others Case Studies
 Figure 14. AI for Pharma and Biotech Report Years Considered
 Figure 15. Global AI for Pharma and Biotech Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global AI for Pharma and Biotech Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global AI for Pharma and Biotech Market Share by Region: 2024 VS 2031
 Figure 18. Global AI for Pharma and Biotech Market Share by Players in 2024
 Figure 19. Global Top AI for Pharma and Biotech Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI for Pharma and Biotech as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by AI for Pharma and Biotech Revenue in 2024
 Figure 21. North America AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America AI for Pharma and Biotech Market Share by Country (2020-2031)
 Figure 23. United States AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe AI for Pharma and Biotech Market Share by Country (2020-2031)
 Figure 27. Germany AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific AI for Pharma and Biotech Market Share by Region (2020-2031)
 Figure 35. China AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America AI for Pharma and Biotech Market Share by Country (2020-2031)
 Figure 43. Mexico AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa AI for Pharma and Biotech Market Share by Country (2020-2031)
 Figure 47. Turkey AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE AI for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. CureMetrix Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 51. Enlitic Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 52. VoxelCloud Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 53. Insilico Medicine Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 54. Oncora Medical Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 55. Atomwise Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 56. TwoXAR Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 57. Berg Health Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 58. CloudMedX Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 59. Deep Genomics Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 60. Johnson & Johnson Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 61. Roche Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 62. Pfizer Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 63. Novartis Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 64. Bayer Revenue Growth Rate in AI for Pharma and Biotech Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart